title: [Hematologic disorders (acute agranulocytosis) during treatment with indalpine].
authors.forename: B
authors.initials: B
authors.lastname: Grosbois
authors.forename: D
authors.initials: D
authors.lastname: Milon
authors.forename: C
authors.initials: C
authors.lastname: Dauriac
authors.forename: P Y
authors.initials: PY
authors.lastname: Leprise
authors.forename: C
authors.initials: C
authors.lastname: Leclech
authors.forename: A
authors.initials: A
authors.lastname: Baert
authors.forename: C
authors.initials: C
authors.lastname: Beneton
mesh_terms: D000208:Acute Disease; D000380:Agranulocytosis / Q000139:chemically induced*; D000928:Antidepressive Agents / Q000009:adverse effects*; D006801:Humans; D010880:Piperidines / Q000009:adverse effects*
chemical_list: D000928:Antidepressive Agents; D010880:Piperidines; C018181:indalpine
vernacular_title: Troubles hématologiques (agranulocytose aigue) au cours d'un traitement par indalpine.